Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

746
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
746
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

264
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
264

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-existing intracranial arterial stenosis independently predicts delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Neuroradiology·2026
Same author

Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE.

AJNR. American journal of neuroradiology·2026
Same author

Middle Meningeal Artery Embolization for Subdural Hematoma: CT/MRI End Points of the EMBOLISE Trial.

Radiology·2026
Same author

Impact of Endoluminal Flow Diverter Number on Aneurysm Treatment Outcomes: A Multicenter Study.

Stroke (Hoboken, N.J.)·2026
Same author

Rural and Urban Disparities in Access to Endovascular Thrombectomy for Large Vessel Occlusions in Colorado.

Stroke·2025
Same author

The Silk Vista Baby Study: A Multicenter Aneurysm Report From North America and Europe.

Neurosurgery·2025

Related Experiment Video

Updated: Sep 21, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.9K

Tailored Treatment Options for Cerebral Cavernous Malformations.

Jessa E Hoffman1, Blake Wittenberg1, Brent Morel1

  • 1Department of Neurosurgery, University of Colorado, Aurora, CO 80045, USA.

Journal of Personalized Medicine
|May 28, 2022
PubMed
Summary

Cerebral cavernous malformations (CCMs) require individualized treatment plans. Intervention is key for symptomatic lesions or those with high hemorrhage risk, with future therapies targeting CCM pathogenesis.

Keywords:
CCMscavernomascerebral cavernous malformations

More Related Videos

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.0K
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
11:58

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

15.7K

Related Experiment Videos

Last Updated: Sep 21, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.9K
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.0K
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
11:58

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

15.7K

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Malformations

Background:

  • Cerebral cavernous malformations (CCMs), also known as cavernomas, are vascular anomalies.
  • Diagnosis and treatment strategies for CCMs are continually advancing.
  • Understanding CCM pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To review the current state of diagnosis and treatment for cerebral cavernous malformations.
  • To emphasize the need for personalized treatment approaches based on CCM characteristics.
  • To discuss potential future directions in medical management of CCMs.

Main Methods:

  • Literature review of recent advancements in CCM diagnosis and treatment.
  • Analysis of indications for intervention in symptomatic or high-risk CCMs.
  • Discussion of emerging therapeutic targets related to CCM pathogenesis.

Main Results:

  • Intervention for CCMs is indicated for symptomatic neurologic deficits, seizures, or high hemorrhage risk.
  • Individualized treatment plans are essential for optimal patient outcomes.
  • Future treatments may focus on the specific molecular pathways driving CCM development.

Conclusions:

  • The management of cerebral cavernous malformations is evolving.
  • Tailored treatment strategies considering individual CCM features are paramount.
  • Targeting CCM pathogenesis represents a promising avenue for future therapeutic development.